Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 4 |
List of Tables | 4 | 1 |
List of Figures | 5 | 1 |
Bellerophon Therapeutics, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
Bellerophon Therapeutics, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
Bellerophon Therapeutics, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
Bellerophon Therapeutics, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
Bellerophon Therapeutics, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
Bellerophon Therapeutics, Inc., Medical Equipment, Deal Details | 11 | 7 |
Venture Financing | 11 | 1 |
Bellerophon Therapeutics Raises Funds through Venture Financing | 11 | 1 |
Partnerships | 12 | 1 |
Bellerophon Therapeutics Extends Licensing Agreement with INO Therapeutics | 12 | 1 |
Bellerophon Enters into Licensing Agreement with Ikaria | 13 | 1 |
Equity Offering | 14 | 1 |
Bellerophon Therapeutics to Raise USD5.7 Million in Public offering of Shares | 14 | 2 |
Bellerophon Therapeutics Raises USD60 Million in IPO | 16 | 2 |
Bellerophon Therapeutics, Inc. - Key Competitors | 18 | 1 |
Key Employees | 19 | 1 |
Locations And Subsidiaries | 20 | 1 |
Head Office | 20 | 1 |
Recent Developments | 21 | 1 |
Financial Announcements | 21 | 1 |
Aug 09, 2016: Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update | 21 | 1 |
May 10, 2016: Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update | 22 | 1 |
Mar 21, 2016: Bellerophon Reports 2015 Financial Results and Provides Business Update | 23 | 2 |
Nov 12, 2015: Bellerophon Reports 2015 Third Quarter Operational and Financial Results | 25 | 1 |
Aug 13, 2015: Bellerophon Reports 2015 Second Quarter Operational and Financial Results | 26 | 2 |
May 15, 2015: Bellerophon Reports 2015 First Quarter Financial and Operational Results | 28 | 1 |
Mar 31, 2015: Bellerophon Reports 2014 Full Year Financial and Operational Results | 29 | 1 |
Corporate Communications | 30 | 1 |
Sep 20, 2016: Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016 | 30 | 1 |
Mar 02, 2016: Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | 31 | 1 |
Feb 23, 2016: Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer | 32 | 1 |
Feb 16, 2016: Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member | 33 | 1 |
Sep 15, 2015: Bellerophon Therapeutics Announces Leadership Team Changes | 34 | 1 |
Jul 01, 2015: Bellerophon Therapeutics Announces Management and Board Additions | 35 | 1 |
May 20, 2015: Bellerophon Therapeutics Adds to Experienced Drug and Device Development Management Team | 36 | 1 |
May 13, 2015: Bellerophon Therapeutics Appoints Two New Independent Board Members | 37 | 1 |
Jan 29, 2015: Bellerophon Therapeutics Strengthens Drug and Device Development Capabilities with Key Management Additions | 38 | 1 |
Product News | 39 | 1 |
Jan 21, 2016: Bellerophon Therapeutics Announces Notice of Intention to Grant a European Patent Supporting Its INOpulse Program | 39 | 1 |
Jan 19, 2016: Bellerophon Therapeutics Receives EC Certification for New INOpulse Drug-Device Delivery System | 40 | 1 |
May 05, 2015: Bellerophon Therapeutics to Present Late-Breaking Poster at the European Society of Cardiology's Heart Failure 2015/2nd World Congress on Acute Heart Failure | 41 | 1 |
Appendix | 42 | 1 |
Methodology | 42 | 1 |
About GlobalData | 42 | 1 |
Contact Us | 42 | 1 |
Disclaimer | 42 | 1 |